The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results